Synopsis: Wockhardt is exiting the US generics market after sustained losses to focus on antibiotics and insulin biologics. This strategic shift aims to drive innovation, profitability, and long-term growth across global markets. During Monday’s trading session,...
During Thursday’s trading session, the shares of a global pharmaceutical company providing access to affordable and innovative medicines tumbled by nearly 2 percent on BSE, after CITI Research trimmed target price and recommended a “sell” rating on the...
Search Topic or Keyword
Easiest Stock Screener Tool!
Best stock discovery tool with +130 filters, built for fundamental analysis. Profitability, Growth, Valuation, Liquidity, and many more filters. Search Stocks Industry-wise, Export Data For Offline Analysis, Customizable Filters.
